Company / Total Assets
IOVANCE BIOTHERAPEUTICS, INC. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$913.2M
FY2025
5-year range
$664.0M / $913.2M
FY2021-FY2025
Trend
+0.3%
vs FY2024
Sector context
#88 of 214
Health Care
What the data says
At $913M, IOVANCE BIOTHERAPEUTICS, INC.'s total assets ranks #88 of 214 in the Health Care sector. Total Assets has increased for 3 consecutive years, from $664M in FY2022 to $913M in FY2025.
Based on SEC 10-K filings.
$913M in FY2025 with a 5-year CAGR of +3.5%.
Improved from $780M to $913M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +11.2%
- 5-Year CAGR
- +3.5%
- 10-Year CAGR
- -
Sector benchmark
#88 of 214 in Health CareTop 41% of 214This company $913.2M Sector average $7.5B
▼
-87.8% below sector average
Key checks
Key Insights
- IOVANCE BIOTHERAPEUTICS, INC.'s total assets has grown for 3 consecutive years.
- 5-year CAGR of +3.5%, indicating consistent growth.
- In FY2025, total assets increased 0.3% year-over-year.
- Ranks #88 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $913.2M | +0.3% |
| FY2024 | $910.4M | +16.7% |
| FY2023 | $780.4M | +17.5% |
| FY2022 | $664.0M | -14.6% |
| FY2021 | $777.3M | +1.2% |
| FY2020 | $768.5M | +123.0% |
| FY2019 | $344.7M | -28.3% |
| FY2018 | $480.8M | +209.5% |
| FY2017 | $155.4M | -9.6% |
| FY2016 | $171.9M | +62.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026